Sagent Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SAGENT PHARMS, and what generic and branded alternatives to SAGENT PHARMS drugs are available?
SAGENT PHARMS has seventy-eight approved drugs.
There is one tentative approval on SAGENT PHARMS drugs.
Drugs and US Patents for Sagent Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sagent Pharms Inc | AMPICILLIN SODIUM | ampicillin sodium | INJECTABLE;INJECTION | 090583-005 | Nov 27, 2015 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Sagent Pharms Inc | PIPERACILLIN AND TAZOBACTAM | piperacillin sodium; tazobactam sodium | INJECTABLE;INJECTION | 208675-001 | Feb 16, 2021 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Sagent Pharms Inc | CISATRACURIUM BESYLATE | cisatracurium besylate | INJECTABLE;INJECTION | 201836-001 | Nov 6, 2020 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Sagent Pharms | HEPARIN SODIUM | heparin sodium | INJECTABLE;INJECTION | 090809-001 | Jun 30, 2010 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Sagent Pharms Inc | CISATRACURIUM BESYLATE | cisatracurium besylate | INJECTABLE;INJECTION | 201836-002 | Nov 6, 2020 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.